Bio Green Med Solution (BGMS) Operating Margin (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Operating Margin of 31.62% for Q1 2026, down 102.37% quarter-over-quarter from 1335.8% in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Operating Margin (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Operating Margin for 12 consecutive years, with 31.62% the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Margin changed N/A year-over-year to 31.62%; the TTM figure through Mar 2026 stood at 467.48% (changed N/A YoY), while the FY2024 annual figure was 27916.28%, down 2185604.0% from the prior year.
- Operating Margin slipped to 31.62% in Q1 2026 per BGMS's latest filing, from 1335.8% in the prior quarter.
- Across five years, Operating Margin topped out at 1335.8% in Q4 2025 and bottomed at 91100.0% in Q2 2024.
- Historically, Operating Margin has averaged 21052.1% across 4 years, with a median of 15017.24% in 2024.
- On a YoY basis, Operating Margin climbed as much as 2101125 bps in 2024 and fell as far as 8951046 bps in 2024.
- Bio Green Med Solution's Operating Margin stood at 17290.32% in 2023, then fell by 26 bps to 21770.0% in 2024, then jumped by 106 bps to 1335.8% in 2025, then tumbled by 102 bps to 31.62% in 2026.
- Business Quant data shows BGMS's Operating Margin at 31.62% in Q1 2026, 1335.8% in Q4 2025, and 1224.69% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | -562.07% |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | - |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 19.06% |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 17.93% |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 19.75% |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -0.36% |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | -124.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -124.40% |
| Mar 31, 2026 | -31.62% |
| Dec 31, 2025 | -162.46% |
| Sep 30, 2025 | -1,224.69% |
| Sep 30, 2024 | -21,770.00% |
| Jun 30, 2024 | -91,100.00% |
| Mar 31, 2024 | -15,017.24% |
| Dec 31, 2023 | -17,290.32% |
| Sep 30, 2023 | -42,781.25% |
| Jun 30, 2023 | -1,589.54% |
| Dec 31, 2018 | -1,643.33% |
| Dec 31, 2016 | -1,144.04% |
| Sep 30, 2016 | -1,696.10% |
| Jun 30, 2016 | -1,693.69% |
| Mar 31, 2016 | -2,693.53% |
| Dec 31, 2015 | -917.10% |
| Sep 30, 2015 | -474.69% |
| Jun 30, 2015 | -1,221.96% |
| Mar 31, 2015 | -1,034.77% |
| Dec 31, 2014 | -2,340.89% |